ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for ADVANCED TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on tough breast cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests an oral drug called Zn-Telomir in 76 adults with advanced or metastatic triple-negative breast cancer that has worsened after prior treatments. The study has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. It is…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising drug trodelvy tested as first defense against aggressive breast cancer
Disease control Not yet recruitingThis phase 2 trial is testing the drug sacituzumab govitecan (Trodelvy) as a first treatment for people with advanced triple-negative breast cancer who haven't had prior therapy for advanced disease. Researchers want to see if the drug can shrink tumors or slow the cancer's growt…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Right care, right time: study tests smart palliative care model for heart failure and cancer
Symptom relief Not yet recruitingThis study tests a flexible palliative care program for people with advanced heart failure or certain cancers. The program adds more team members—like a social worker or nurse—as symptoms get worse. The goal is to improve quality of life and match care to each person's changing n…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New study aims to stop Chemo-Induced diarrhea in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether giving atropine before treatment can prevent diarrhea in people with advanced breast cancer receiving the drug sacituzumab govitecan. About 30 participants will receive atropine alongside their cancer therapy. The goal is to improve treatment tolerance an…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC